CA2220703A1 - Compositions pharmaceutiques pour le traitement de l'alcoolisme - Google Patents

Compositions pharmaceutiques pour le traitement de l'alcoolisme

Info

Publication number
CA2220703A1
CA2220703A1 CA002220703A CA2220703A CA2220703A1 CA 2220703 A1 CA2220703 A1 CA 2220703A1 CA 002220703 A CA002220703 A CA 002220703A CA 2220703 A CA2220703 A CA 2220703A CA 2220703 A1 CA2220703 A1 CA 2220703A1
Authority
CA
Canada
Prior art keywords
treatment
pharmaceutical compositions
alcohol addiction
addiction
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002220703A
Other languages
English (en)
Other versions
CA2220703C (fr
Inventor
Paolo Morazzoni
Ezio Bombardelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena S.P.A.
Paolo Morazzoni
Ezio Bombardelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A., Paolo Morazzoni, Ezio Bombardelli filed Critical Indena S.P.A.
Publication of CA2220703A1 publication Critical patent/CA2220703A1/fr
Application granted granted Critical
Publication of CA2220703C publication Critical patent/CA2220703C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Addiction (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002220703A 1995-05-12 1996-05-08 Compositions pharmaceutiques pour le traitement de l'alcoolisme Expired - Fee Related CA2220703C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI950958A IT1274481B (it) 1995-05-12 1995-05-12 Composizioni farmaceutiche per il trattamento della alcol-dipendenza
ITMI95A000958 1995-05-12
PCT/EP1996/001916 WO1996035441A1 (fr) 1995-05-12 1996-05-08 Compositions pharmaceutiques pour le traitement de l'alcoolisme

Publications (2)

Publication Number Publication Date
CA2220703A1 true CA2220703A1 (fr) 1996-11-14
CA2220703C CA2220703C (fr) 2001-07-24

Family

ID=11371582

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002220703A Expired - Fee Related CA2220703C (fr) 1995-05-12 1996-05-08 Compositions pharmaceutiques pour le traitement de l'alcoolisme

Country Status (17)

Country Link
US (1) US5904923A (fr)
EP (1) EP0824356B1 (fr)
JP (1) JP2955370B2 (fr)
KR (1) KR100290029B1 (fr)
CN (1) CN1066336C (fr)
AT (1) ATE221384T1 (fr)
AU (1) AU695010B2 (fr)
CA (1) CA2220703C (fr)
DE (1) DE69622704T2 (fr)
DK (1) DK0824356T3 (fr)
ES (1) ES2180783T3 (fr)
HK (1) HK1009096A1 (fr)
IT (1) IT1274481B (fr)
NO (1) NO318659B1 (fr)
PT (1) PT824356E (fr)
RU (1) RU2153345C2 (fr)
WO (1) WO1996035441A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3570989B2 (ja) 1997-07-30 2004-09-29 インデナ エッセ ピ ア 大豆抽出物、その調製方法および医薬組成物
US5968746A (en) 1997-11-26 1999-10-19 Schneider; David R. Method and apparatus for preserving human saliva for testing
WO2002012218A1 (fr) * 2000-08-03 2002-02-14 Hong Kong University Of Science And Technology Antagonistes des recepteurs du n-methyl-d-aspartate
CN1304723A (zh) * 2001-01-16 2001-07-25 中山大学 含二氢呋喃环结构的丹参酮类化合物用于治疗肝性脑病的药物
US6852342B2 (en) 2002-03-26 2005-02-08 Avoca, Inc. Compounds for altering food intake in humans
AU2002362159A1 (en) * 2002-12-31 2004-07-22 Zhongshan Univertsity Tanshinone iia for prophylaxising or treating atherosclerosis
US9827314B2 (en) * 2003-12-08 2017-11-28 Mars, Incorporated Edible compositions which are adapted for use by a companion animal
EP1868593A2 (fr) * 2005-04-07 2007-12-26 Hythiam, Inc. Procedes ameliores et compositions permettant de prevenir l'anxiete, l'abus d'une substance et la dependance
GB201312205D0 (en) * 2013-07-08 2013-08-21 Univ Leuven Kath Anticonvulsant activity of dan shen extracting compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1239281B (it) * 1989-10-27 1993-10-19 Indena Spa Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse

Also Published As

Publication number Publication date
CA2220703C (fr) 2001-07-24
NO318659B1 (no) 2005-04-25
EP0824356B1 (fr) 2002-07-31
ITMI950958A0 (it) 1995-05-12
HK1009096A1 (en) 1999-05-28
EP0824356A1 (fr) 1998-02-25
JP2955370B2 (ja) 1999-10-04
RU2153345C2 (ru) 2000-07-27
WO1996035441A1 (fr) 1996-11-14
DE69622704D1 (de) 2002-09-05
CN1066336C (zh) 2001-05-30
AU5815396A (en) 1996-11-29
KR19990014692A (ko) 1999-02-25
KR100290029B1 (ko) 2001-05-15
NO975177D0 (no) 1997-11-11
NO975177L (no) 1997-11-11
US5904923A (en) 1999-05-18
DK0824356T3 (da) 2002-11-25
IT1274481B (it) 1997-07-17
AU695010B2 (en) 1998-08-06
ITMI950958A1 (it) 1996-11-12
ES2180783T3 (es) 2003-02-16
JPH10512583A (ja) 1998-12-02
PT824356E (pt) 2002-12-31
CN1184429A (zh) 1998-06-10
DE69622704T2 (de) 2003-04-03
ATE221384T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
CA2192433A1 (fr) Composes anti-herpesvirus et methodes de caracterisation, de production et d'utilisation
EP0727217A3 (fr) Compositions pharmaceutiques et cosmétiques contenant ellagitannin du type god comme principe actif
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU1180997A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
IL116674A (en) Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
GR3031526T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
CA2233277A1 (fr) Extrait stable d'hypericum perforatum l., son procede de preparation et compositions pharmaceutiques
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
AU4865597A (en) Pharmaceutical and cosmetic formulations with antiacne activity
GR3033591T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
CA2220703A1 (fr) Compositions pharmaceutiques pour le traitement de l'alcoolisme
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
CA2337667A1 (fr) Conjugues dextrane-leptine, compositions pharmaceutiques et methodes connexes
AU5402896A (en) New taxoids, their preparation and pharmaceutical compositions containing same
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
BG103196A (en) Crystalline pharmaceutical product
HUP9702479A3 (en) New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
GR3036411T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130508